Advertisement
Screener

FITLIFE BRANDS, INC. (FTLF) Overview

FITLIFE BRANDS, INC. (FTLF) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.20; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.17; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.09; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.18; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$8.44$10.20$12.33$14.91$18.03$21.802025-09-292026-09-29$4.51$6.18$8.47$11.61$15.91$21.802021-09-292026-09-29$0.02$0.10$0.37$1.45$5.62$21.802016-09-292026-09-29$0.02$0.10$0.37$1.45$5.62$21.802009-01-022026-09-29$0.02$0.10$0.37$1.45$5.62$21.802009-01-022026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$9.09
Previous close
$9.29
Change
-$0.20
Change (%)
-2.15%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

FTLF
-44.13%
S&P 500
(m)

1 year

FTLF
-54.34%
S&P 500
(m)

3 years

FTLF
-0.44%
S&P 500
(m)

5 years

FTLF
+38.51%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.20

0.010.100.200.290.3831 Mar 2025: estimate (m); actual 0.2031 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.1830 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.0930 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.1731 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.2030 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.20(m)(m)
1 Jan 202631 Mar 2026(m)0.17(m)(m)
1 Jul 202530 Sept 2025(m)0.09(m)(m)
1 Apr 202530 Jun 2025(m)0.18(m)(m)
1 Jan 202531 Mar 2025(m)0.20(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.20

0.120.420.711.011.3131 Dec 2021: estimate (m); actual 1.1331 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.8931 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.5431 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.9131 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.2031 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.20(m)(m)
1 Jan 202431 Dec 2024(m)0.91(m)(m)
1 Jan 202331 Dec 2023(m)0.54(m)(m)
1 Jan 202231 Dec 2022(m)0.89(m)(m)
1 Jan 202131 Dec 2021(m)1.13(m)(m)

Revenue vs. Earnings

USD

30 Sept 2021 ■ Revenue 6.71M ■ Earnings 1.13M — Profit margin 16.78%

-0.98M15.8%2.39M18.5%5.75M21.1%9.12M23.8%30 Sept 2020: revenue 6.92M; earnings 1.38M; profit margin 19.93%30 Sept 202031 Mar 2021: revenue 6.16M; earnings 1.41M; profit margin 22.82%31 Mar 202130 Jun 2021: revenue 8.14M; earnings 1.63M; profit margin 20.05%30 Jun 202130 Sept 2021: revenue 6.71M; earnings 1.13M; profit margin 16.78%30 Sept 2021

31 Dec 2020 ■ Revenue 21.74M ■ Earnings 8.82M — Profit margin 40.59%

-3.04M0.5%7.43M14.2%17.89M27.9%28.35M41.6%31 Dec 2016: revenue 25.31M; earnings 0.37M; profit margin 1.45%31 Dec 201631 Dec 2018: revenue 17.08M; earnings 0.51M; profit margin 2.98%31 Dec 201831 Dec 2019: revenue 19.50M; earnings 2.61M; profit margin 13.39%31 Dec 201931 Dec 2020: revenue 21.74M; earnings 8.82M; profit margin 40.59%31 Dec 2020

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$9.09(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$9.09High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning FTLF

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Sept 2021.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$9.98M
Profit margin
37.06%
Return on assets · 12 month
66.07%
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
11.73K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-2.36%*
Total return · month
-7.15%*
Total return · quarter
-17.81%*
Total return · half year
-36.34%*
Total return · year to date
-44.13%*
Total return · 1 year
-54.34%*
Total return · 3 years
-0.44%*
Total return · 5 years
38.51%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$26.93M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

FITLIFE BRANDS, INC. Overview

View more →

(m)

(m)

SEC CIK
1374328
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Country of operation
United States
Business address
5214 S. 136TH STREET, OMAHA, Nebraska, 68137, United States
Fiscal year end
1231
Phone
402-884-1894

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87